Results 41 to 50 of about 3,909 (222)
Vasopressin and terlipressin in adult vasodilatory shock [PDF]
Critical Care, 2012 We have read with interest the study by Serpa Neto and colleagues showing that vasopressin use in vasodilatory shock is associated with reduced mortality [1]. However, we believe there are three aspects that need clarification. In relation to the paper recently published by our group on the same topic, the authors correctly state that 'we only ...
Polito, Angelo +4 more
openaire +3 more sources
Severe Bradycardia Associated with the Use of Terlipressin: A Case Report
Case Reports in GastroenterologyIntroduction: Although terlipressin is known to cause bradycardia, this adverse effect is usually described in association with hypertension and is considered a benign compensatory response mediated by arterial baroreceptors.
Alex Yartsev, Jessica T. Nguyen
doaj +1 more source
BMC Anesthesiology, 2019 Background Terlipressin, in general, is a vasopressor which acts via V1 receptors. Its infusion elevates mean blood pressure and can reduce bleeding which has a splanchnic origin.
Magdy Mohammed Mahdy +12 more
doaj +1 more source
Terlipressin-Associated Complete Heart Block. [PDF]
ACG Case Rep JABSTRACT Terlipressin has been recently approved in the United States to treat hepatorenal syndrome, a feared complication of both acute and chronic liver diseases. Side effects of the medication have been studied through clinical trials and the precedent use in Europe, as well as extrapolation from its analog vasopressin.
Song J, Alfie T, Heist EK, Chung RT.
europepmc +3 more sources
Scientific Reports, 2022 Hemorrhagic shock (HS), a major cause of trauma-related mortality, is mainly treated by crystalloid fluid administration, typically with lactated Ringer’s (LR).
Leticia Urbano Cardoso Castro +10 more
doaj +1 more source
Alimentary Pharmacology &Therapeutics, EarlyView.In a pooled analysis, bradycardia was observed in 6% of terlipressin‐treated patients but rarely required a dose interruption or reduction. Arrhythmia serious adverse event incidences were low and similar in both treatment groups. Routine intensive cardiac monitoring for the detection of arrhythmias may not be necessary during terlipressin ...
Jasmohan S. Bajaj +6 more
wiley +1 more source
Terlipressin-Related Acute Myocardial Infarction: A Case Report and Literature Review
Kaohsiung Journal of Medical Sciences, 2004 Acute ST-segment elevation myocardial infarction after the administration of terlipressin in patients with hemorrhagic esophageal varices is a rare but life-threatening complication.
Min-Yi Lee +7 more
doaj +1 more source
Management Strategies for Refractory Esophageal Varices
DEN Open, Volume 6, Issue 1, April 2026.ABSTRACT Refractory esophageal varices that are difficult to control or unresponsive to endoscopic treatment remain a major clinical challenge in the management of portal hypertension. This review provides a comprehensive overview of treatment strategies for these cases, along with a comparative analysis of the American Association for the Study of ...
Keita Maki, Hiroaki Haga, Yoshiyuki Ueno
wiley +1 more source
The FASEB Journal, Volume 39, Issue 17, 15 September 2025.The study involved patients who experienced acute kidney injury (AKI) following liver transplantation at the Third Affiliated Hospital of Sun Yat‐sen University from January 2015 to February 2023. Patients were categorized into CKD and non‐CKD groups based on their progression to chronic kidney disease (CKD) 3 months post‐surgery.
Liping Li +9 more
wiley +1 more source
Cutaneous Ischaemia Following Terlipressin Therapy for Hepatorenal Syndrome [PDF]
Journal of Clinical and Diagnostic Research, 2018 Hepatorenal Syndrome (HRS) is a potentially fatal complication of hepatic failure and portal hypertension. Among the various treatments available including octreotide, midodrine and albumin, the current standard of care for stable patients is ...
Aneesh Basheer +3 more
doaj +1 more source